US FDA consults on regulation of products involving nanotechnology
This article was originally published in RAJ Devices
Executive Summary
The US Food and Drug Administration is seeking feedback on a draft guideline that outlines its views on whether a regulated product contains nanomaterials or otherwise involves the use of nanotechnology1,2.